FI965202L - Farmaseuttiset takriinikoostumukset - Google Patents

Farmaseuttiset takriinikoostumukset Download PDF

Info

Publication number
FI965202L
FI965202L FI965202A FI965202A FI965202L FI 965202 L FI965202 L FI 965202L FI 965202 A FI965202 A FI 965202A FI 965202 A FI965202 A FI 965202A FI 965202 L FI965202 L FI 965202L
Authority
FI
Finland
Prior art keywords
tacrine
pharmaceutical
compositions
tacrine compositions
pharmaceutical tacrine
Prior art date
Application number
FI965202A
Other languages
English (en)
Swedish (sv)
Other versions
FI965202A0 (fi
FI965202A7 (fi
Inventor
George V Guittard
Jerry D Childers
Patrick S-L Wong
Fernando E Gumucio
David J Kidney
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI965202L publication Critical patent/FI965202L/fi
Publication of FI965202A0 publication Critical patent/FI965202A0/fi
Publication of FI965202A7 publication Critical patent/FI965202A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI965202A 1994-06-27 1995-06-14 Farmaseuttiset takriinikoostumukset FI965202A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/266,045 US5698224A (en) 1994-06-27 1994-06-27 Tacrine therapy
PCT/US1995/007726 WO1996000065A1 (en) 1994-06-27 1995-06-14 Tacrine pharmaceutical compositions

Publications (3)

Publication Number Publication Date
FI965202L true FI965202L (fi) 1996-12-23
FI965202A0 FI965202A0 (fi) 1996-12-23
FI965202A7 FI965202A7 (fi) 1996-12-23

Family

ID=23012934

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965202A FI965202A7 (fi) 1994-06-27 1995-06-14 Farmaseuttiset takriinikoostumukset

Country Status (11)

Country Link
US (2) US5698224A (fi)
EP (1) EP0768880A1 (fi)
JP (1) JPH10507440A (fi)
KR (1) KR970703768A (fi)
AU (1) AU685297B2 (fi)
CA (1) CA2187332A1 (fi)
FI (1) FI965202A7 (fi)
MX (1) MX9700081A (fi)
NO (1) NO965539L (fi)
NZ (1) NZ288951A (fi)
WO (1) WO1996000065A1 (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408465D0 (en) * 1994-04-27 1994-06-22 Univ Mcgill Apolipoprotein e polymorphism & treatment of alzheimer's disease
US7049078B2 (en) 1994-04-27 2006-05-23 Judés Poirier Apolipoprotein E polymorphism and treatment of alzheimer's disease
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5593769A (en) * 1995-06-14 1997-01-14 Minnesota Mining And Manufacturing Company Polyurethane pad covering for gel filled articles
ATE314054T1 (de) * 1996-10-25 2006-01-15 Shire Lab Inc Osmotisches verabreichungssystem für lösliche dosen
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ES2264173T3 (es) * 1996-11-25 2006-12-16 Alza Corporation Forma de dosificacion para suministrar una dosis creciente.
US6251587B1 (en) 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
BR9914251A (pt) * 1998-10-01 2001-06-19 Novartis Ag Formulações orais de liberação sustentada
HUP0104993A3 (en) * 1998-11-02 2003-02-28 Alza Corp Mountain View Method and device for controlled delivery of active agents
PT1126853E (pt) * 1998-11-02 2006-07-31 Alza Corp Distribuicao controlada de anti-depressivos
US6524616B1 (en) * 1999-06-25 2003-02-25 Wake Forest University Health Services Compositions and methods for treating or preventing neurodegeneration and cognitive decline and dysfunction associated with alzheimer's disease, aging, other dementia related disorders and estrogen deficiency related conditions
WO2001037815A1 (en) * 1999-11-22 2001-05-31 Alza Corporation Osmotic dosage form comprising first and second
US20020015731A1 (en) * 1999-12-23 2002-02-07 Appel Leah E. Hydrogel-Driven Drug Dosage Form
EP1239839A2 (en) 1999-12-23 2002-09-18 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
USD485963S1 (en) 2000-11-08 2004-02-03 Mars Uk Limited Confectionery product
USD483547S1 (en) 2000-11-08 2003-12-16 Mars Uk Limited Confectionery product
USD459570S1 (en) 2001-04-26 2002-07-02 Houston Harvest Gift Products, Llc Pet treat
ATE356625T1 (de) * 2001-11-30 2007-04-15 Pfizer Prod Inc Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14- triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )- hexadeca-2(11) 3, 5,7, 9-pentaene
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
WO2005051389A1 (en) * 2003-11-21 2005-06-09 Memory Pharmaceuticals Corporation Using of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
JP2008500368A (ja) * 2004-05-27 2008-01-10 ミジェニックス コーポレイション 細胞保護のための２置換１７−イミノエストロゲン化合物
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
WO2006060186A2 (en) * 2004-11-30 2006-06-08 Bayer Pharmaceuticals Corporation Pyrazole derivatives for the treatment of dementia and related disorders
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
WO2006106514A2 (en) * 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
KR101213345B1 (ko) * 2005-04-28 2012-12-17 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매약을 함유하는 조성물
CN101534808A (zh) * 2005-06-27 2009-09-16 拜维尔实验室国际有限公司 丁氨苯丙酮盐的改良释放配制品
EP2258358A3 (en) * 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
KR20090007568A (ko) * 2006-04-24 2009-01-19 화이자 프로덕츠 인코포레이티드 약물 전달 장치용 비대칭 막
WO2008001341A1 (en) * 2006-06-27 2008-01-03 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
WO2010077988A2 (en) * 2008-12-16 2010-07-08 Jerzy Alexander Georgiades Role of proline rich peptides in cellular communication mechanisms and treatment of diseases
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法
USD666376S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD666377S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2014197744A1 (en) 2013-06-05 2014-12-11 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
CN105030714A (zh) * 2015-07-06 2015-11-11 长春中医药大学 阿尼西坦缓释片及其制备方法
GB201602145D0 (en) 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
USD805726S1 (en) * 2016-03-11 2017-12-26 Mars, Incorporated Pet food
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина
ES3038192T3 (en) * 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU1589492A (en) * 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
EP0711166A1 (en) * 1993-07-22 1996-05-15 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
EP0788793A1 (en) * 1996-02-01 1997-08-13 Takeda Chemical Industries, Ltd. Idebenone for the treatment of dementia

Also Published As

Publication number Publication date
KR970703768A (ko) 1997-08-09
NO965539L (no) 1997-02-25
US6036973A (en) 2000-03-14
AU685297B2 (en) 1998-01-15
FI965202A0 (fi) 1996-12-23
JPH10507440A (ja) 1998-07-21
NO965539D0 (no) 1996-12-23
FI965202A7 (fi) 1996-12-23
AU2864495A (en) 1996-01-19
MX9700081A (es) 1997-04-30
NZ288951A (en) 1997-04-24
CA2187332A1 (en) 1996-01-04
US5698224A (en) 1997-12-16
WO1996000065A1 (en) 1996-01-04
EP0768880A1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
FI965202A7 (fi) Farmaseuttiset takriinikoostumukset
FI20071025L (fi) Farmaseuttisia koostumuksia
IS4706A (is) Lyfjasamsetningar
FI974241A0 (fi) BPM-15 -koostumukset
ID18352A (id) Komposisi-komposisi farmasi
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
FI972054A7 (fi) Immunogeenisiä koostumuksia
BR9507768A (pt) Composição farmacêutica
FI943705L (fi) Farmaseuttiset koostumukset
EE9900440A (et) Farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
EE200000330A (et) Farmatseutilised kompositsioonid
MA23731A1 (fr) Compositions detegentes
FI940726A7 (fi) Farmaseuttiset koostumukset
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen
NO970747D0 (no) Sammensetninger
FI962738L (fi) Farmaseuttiset koostumukset
FI954050A7 (fi) Lääkekoostumuksia
DK0599461T3 (da) Hærdelige sammensætninger
NO994436L (no) Farmasöytiske sammensetninger